etoposide has been researched along with Pyoderma Gangrenosum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, N; Fujiwara, D; Hamada, T; Iwatsuki, K; Kawakami, Y; Saeki, K; Sando, Y; Yamasaki, O | 1 |
| Browne, A; Carney, D; Fitzgibbons, J; Ho, KK; Powell, FC | 1 |
2 other study(ies) available for etoposide and Pyoderma Gangrenosum
| Article | Year |
|---|---|
Successful use of etoposide for pyoderma gangrenosum associated with myelodysplastic syndrome and trisomy 8: cytokine profiles during treatment.
Topics: Antineoplastic Agents, Phytogenic; C-Reactive Protein; Chromosomes, Human, Pair 8; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-8; Middle Aged; Myelodysplastic Syndromes; Prothrombin Time; Pyoderma Gangrenosum; Trisomy | 2017 |
Mycosis fungoides bullosa simulating pyoderma gangrenosum.
Topics: Antineoplastic Agents, Phytogenic; Diagnosis, Differential; Etoposide; Fatal Outcome; Female; Humans; Middle Aged; Mycosis Fungoides; PUVA Therapy; Pyoderma Gangrenosum | 2000 |